Financial Ratios

LINK PHARMA CHEM LTD.

NSE : NABSE : 524748ISIN CODE : INE302F01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE45.000.89 (+2.02 %)
PREV CLOSE ( ) 44.11
OPEN PRICE ( ) 44.11
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1764
TODAY'S LOW / HIGH ( )43.55 45.00
52 WK LOW / HIGH ( ) 34.1168.77
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)1.474.242.442.141.48
   CEPS(Rs)3.556.334.414.233.50
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)33.8732.6028.2925.7523.38
   Tax Rate(%)26.1928.2235.3734.0929.24
Margin Ratios
   Core EBITDA Margin(%)5.965.988.5210.218.24
   EBIT Margin(%)4.255.746.097.085.37
   Pre Tax Margin(%)2.294.894.825.663.80
   PAT Margin (%)1.693.513.123.732.69
   Cash Profit Margin (%)4.075.255.637.376.34
Performance Ratios
   ROA(%)2.136.844.825.143.74
   ROE(%)4.4313.929.048.716.53
   ROCE(%)7.3816.5713.5812.8710.31
   Asset Turnover(x)1.261.951.551.381.39
   Sales/Fixed Asset(x)2.914.382.992.202.13
   Working Capital/Sales(x)12.7718.105.934.5210.62
Efficiency Ratios
   Fixed Capital/Sales(x)0.340.230.330.450.47
   Receivable days42.3637.2055.2857.5946.39
   Inventory Days80.0824.7221.6432.2540.99
   Payable days95.1156.98101.20117.50108.63
Valuation Parameters
   PER(x)24.859.509.687.9716.80
   PCE(x)10.316.365.364.037.12
   Price/Book(x)1.081.230.840.661.07
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)0.640.440.270.360.55
   EV/Core EBITDA(x)9.665.843.113.326.11
   EV/EBIT(x)15.067.614.395.0310.26
   EV/CE(x)0.760.810.360.480.75
   M Cap / Sales0.420.330.300.300.45
Growth Ratio
   Net Sales Growth(%)-27.6453.8536.683.964.11
   Core EBITDA Growth(%)-35.7633.679.6123.51-22.32
   EBIT Growth(%)-46.3945.0317.5537.00-33.76
   PAT Growth(%)-65.2373.4614.2144.33-42.00
   EPS Growth(%)-65.2373.4614.2044.33-42.00
Financial Stability Ratios
   Total Debt/Equity(x)0.580.440.290.310.25
   Current Ratio(x)1.211.281.632.631.47
   Quick Ratio(x)0.370.831.362.160.88
   Interest Cover(x)2.166.814.814.993.41
   Total Debt/Mcap(x)0.540.360.350.470.24

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.